Concorde Asset Management’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.6K | Buy |
|
|||||
|
2025
Q1 | $37.6K | Hold |
|
|||||
|
2024
Q4 | $32.4K | Hold |
|
|||||
|
2024
Q3 | $44K | Hold |
|
|||||
|
2024
Q2 | $30.9K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $60K | Hold |
|
|||||
|
2023
Q3 | $50.6K | Sell |
|
|||||
|
2023
Q2 | $49.5K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $65.9K | Sell |
|
|||||
|
2022
Q3 | $79K | Sell |
|
|||||
|
2022
Q2 | $49K | Hold |
|
|||||
|
2022
Q1 | $44K | Hold |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2021
Q3 | $62K | Hold |
|
|||||
|
2021
Q2 | $50K | Hold |
|
|||||
|
2021
Q1 | $61K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $30K | Sell |
|
|||||
|
2018
Q1 | $53K | Hold |
|
|||||
|
2017
Q4 | $27K | Sell |
|
|||||
|
2017
Q3 | $36K | Buy |
|